BP
BNTX icon

BNP Paribas’s BioNTech BNTX Stock Holding History

BNP Paribas’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Hold
40
– – ﹤0.01% 304
2026
Q1 		$3.5K Sell
40
-50
-56% -$5.14K ﹤0.01% 311
2025
Q4 		$8.57K Hold
90
– – ﹤0.01% 317
2025
Q3 		$8.88K Hold
90
– – ﹤0.01% 306
2025
Q2 		$9.58K Hold
90
– – ﹤0.01% 310
2025
Q1 		$8.2K Hold
90
– – ﹤0.01% 320
2024
Q4 		$10.3K Hold
90
– – ﹤0.01% 329
2024
Q3 		$10.7K Hold
90
– – ﹤0.01% 320
2024
Q2 		$7.23K Hold
90
– – ﹤0.01% 299
2024
Q1 		$8.3K Buy
+90
New +$8.63K ﹤0.01% 304

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

BNP Paribas's BNTX Position: Q2 2026 in Review

BNP Paribas held its BioNTech (BNTX) position steady in Q2 2026 at 40 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

BNP Paribas first reported a position in BNTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.7K in Q3 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • BNP Paribas held 40 shares of BioNTech worth $3.75K as of Q2 2026.
  • BNP Paribas left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of BNP Paribas's portfolio in Q2 2026, its #304 holding.
  • BNP Paribas first reported a position in BioNTech in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas's BioNTech position peaked at $10.7K in Q3 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.